Endocrinology-Hormones

Small molecules play a pivotal role in Endocrinology Research. These are low molecular weight compounds that have a significant impact on the endocrine system, hormones, and their receptors. Here are some key aspects of how small molecules are involved in this field:

  • Hormone Mimetics and Inhibitors: Small molecules are used to develop synthetic compounds that mimic the actions of hormones or inhibit their effects. For example, drugs like metformin for diabetes management and selective estrogen receptor modulators (SERMs) for breast cancer treatment are used to either mimic or block hormonal activity.
  • Receptor Modulation: Small molecules can bind to hormone receptors and modulate their activity. This is crucial in developing drugs that target specific hormone receptors, like the use of small molecule agonists and antagonists to regulate thyroid hormone receptors.
  • Metabolism Regulation: Endocrinology research often focuses on metabolism and how hormones like insulin regulate it. Small molecules are employed to understand and develop drugs targeting enzymes involved in metabolism, such as glucagon-like peptide-1 (GLP-1) agonists for diabetes treatment.
  • Steroid Hormone Production: Small molecules may be utilized to influence the production of steroid hormones in the adrenal glands or gonads. This is essential for conditions like Cushing's syndrome or polycystic ovary syndrome (PCOS).
  • Hormone Assays: In laboratory research, small molecules are used as tracers or markers in hormone assays. For instance, small molecule fluorophores can be attached to antibodies to detect hormone levels in blood samples.

Drug Development: Endocrinology research relies on small molecules as potential drug candidates. Researchers design and test small molecules for their effectiveness in modulating hormonal pathways, with the goal of developing new therapies for endocrine disorders.
In summary, small molecules are indispensable tools in Endocrinology Research, enabling scientists to better understand the endocrine system's intricacies and develop novel treatments for a wide range of hormonal disorders and conditions. Their versatility and specificity make them valuable assets in advancing our knowledge of endocrinology and improving patient care.


Endocrinology Disease Products


Endocrinology Research Products

Kisspeptin Receptor

Leptin Receptors

Melanocortin (MC) Receptors

Mineralocorticoid Receptors

Ghrelin Receptors

Natriuretic Peptide Receptors

NPY Receptors

Motilin Receptor

PTH Receptor

Shop By

8 Items

per page
Set Descending Direction
目录号
产品名
应用
产品描述
文献引用
  1. Aromatase inhibitor

    Anastrozole 是一种第三代非甾体选择性芳香化酶抑制剂。与其他芳香化酶抑制剂相比,它可能提供更高的选择性,没有任何固有的内分泌效应,并且对肾上腺类固醇的合成没有明显影响。
  2. Aromatase Inhibitor

    Chrysin 是一种从蓝色钟情花(Passiflora caerulea)中化学提取的天然存在的黄酮。研究显示,它能够引发抗炎效果,这主要是通过抑制 COX-2 表达和通过 IL-6 信号传导实现的。在啮齿动物的体内研究中,发现chrysin具有抗焦虑作用。
  3. Aromatase inhibitor

    Exemestane 是一种口服类固醇芳香化酶抑制剂,用于治疗绝经后妇女的ER阳性乳腺癌,通常与手术和/或放疗联合使用。
  4. Aromatase inhibitor

    Fulvestrant 是一种雌激素受体拮抗剂,没有激动剂效应,其作用机制包括降调和降解雌激素受体。
  5. Aromatase inhibitor

    Letrozole 是一种芳香酶抑制剂。CGS 20267 是一种新型非甾体化合物,能够在体外(IC50 为 11.5 nM)和体内(ED50 为 1-3 微克/千克,口服)强效抑制芳香酶。
  6. Aromatase inhibitor

    Fadrozole 是一种非甾体类芳香化酶抑制剂,在体内对芳香化酶系统显示出非常强大且选择性的抑制作用,并在体内抑制雌激素的生物合成。
  7. aromatase inhibitor

    Alpha-Naphthoflavone 是一种合成黄酮类化合物,作为一种强效且具有竞争性的芳香化酶抑制剂,其 IC50 和 Ki 分别为 0.5 和 0.2 微摩尔。
  8. Aromatase inhibitor

    Fadrozole hydrochloride 是一种强效、选择性且非甾体的芳香化酶抑制剂,其 IC50 为 6.4 nM。

8 Items

per page
Set Descending Direction
苏ICP备14027875号-1